Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_assertion type Assertion NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_head.
- NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_assertion wasGeneratedBy ECO_0000203 NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_provenance.
- NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_assertion wasDerivedFrom gad-20150221 NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_provenance.
- NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_assertion SIO_000772 11865668 NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_provenance.
- NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_assertion evidence source_evidence_literature NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_provenance.
- NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_assertion description "[Thus, polymorphic enzymes such as CYP2C19 and NAT2 can be used to probe changes in drug-metabolizing enzyme capacities. The development of genotype/phenotype discordances should reflect general changes in metabolic capabilities and, thus, alterations in t]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73170.RAyde6HooeKYUIWjEzx10_ixzMy3HuqjBPSklhJp7o3HU130_provenance.